EPAS1 encodes a transcription factor called hypoxia-inducible factor 2-alpha (HIF-2α), which is the driver promoting the development and progression of ccRCC.63 Our work revealed potential metabolic targets in the treatment of different immune-related subgroups. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.